Med-corp Home Health, Inc | |
3310 Chandler Rd, Muskogee, Oklahoma 74403 | |
(918) 687-8033 | |
Name | Med-corp Home Health, Inc |
---|---|
Location | 3310 Chandler Rd, Muskogee, Oklahoma |
Certified By | Medicare |
Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
Medicare ID | 377222 |
Ownership Type | Proprietary |
Service Area Zip Codes | 74016, 74017, 74018, 74019, 74036, 74053, 74105, 74106, 74332, 74337, 74361, 74369, 74401, 74403, 74426, 74434, 74435, 74436, 74441, 74446, 74454, 74455, 74464, 74467, 74470 |
NPI Number | 1528170578 |
Organization Name | MED-CORP HOME HEALTH, INC. |
Address | 3310 Chandler Rd, Muskogee, OK 74403 |
Phone Number | 918-687-8033 |
News Archive
ImmunoCellular Therapeutics, Ltd. today announced initiation of a phase I clinical trial of cancer vaccine ICT-121 as a potential treatment for patients with recurrent glioblastoma multiforme.
Pfizer Inc. announced today that the European Commission has granted conditional marketing authorization for BOSULIF (bosutinib) in the European Union for the treatment of adult patients with chronic phase, accelerated phase and blast phase Philadelphia chromosome positive chronic myelogenous leukemia previously treated with one or more tyrosine kinase inhibitor(s) and for whom imatinib, nilotinib and dasatinib are not considered appropriate treatment options.
ClearCount Medical Solutions, an innovator of patient safety solutions for the operating room, announced today that the editors of Popular Science have named the SmartSponge® System one of the top technology innovations of 2009. As a winner off a "Best of What's New" award in the health category, the SmartSponge System stands out as the first and only system to incorporate the efficiency of counting with the safety of detection for the prevention of left-behind sponges during surgery.
A study that included more than 100,000 patients who received implantable cardioverter-defibrillators (ICDs) found that about 20 percent did not meet evidence-based guidelines for receipt of an ICD, and that these patients had a significantly higher risk of in-hospital death than individuals who met criteria for receiving an ICD, according to a study in the January 5 issue of JAMA.
More than 200 CT scans delivered eight times the normal dose of radiation to potential stroke patients in a Los Angeles area hospital since February 2008 because of a scanner reset, The Los Angeles Times reports.
› Verified 7 days ago
Quality Rating: |
News Archive
ImmunoCellular Therapeutics, Ltd. today announced initiation of a phase I clinical trial of cancer vaccine ICT-121 as a potential treatment for patients with recurrent glioblastoma multiforme.
Pfizer Inc. announced today that the European Commission has granted conditional marketing authorization for BOSULIF (bosutinib) in the European Union for the treatment of adult patients with chronic phase, accelerated phase and blast phase Philadelphia chromosome positive chronic myelogenous leukemia previously treated with one or more tyrosine kinase inhibitor(s) and for whom imatinib, nilotinib and dasatinib are not considered appropriate treatment options.
ClearCount Medical Solutions, an innovator of patient safety solutions for the operating room, announced today that the editors of Popular Science have named the SmartSponge® System one of the top technology innovations of 2009. As a winner off a "Best of What's New" award in the health category, the SmartSponge System stands out as the first and only system to incorporate the efficiency of counting with the safety of detection for the prevention of left-behind sponges during surgery.
A study that included more than 100,000 patients who received implantable cardioverter-defibrillators (ICDs) found that about 20 percent did not meet evidence-based guidelines for receipt of an ICD, and that these patients had a significantly higher risk of in-hospital death than individuals who met criteria for receiving an ICD, according to a study in the January 5 issue of JAMA.
More than 200 CT scans delivered eight times the normal dose of radiation to potential stroke patients in a Los Angeles area hospital since February 2008 because of a scanner reset, The Los Angeles Times reports.
› Verified 7 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often the home health team began their patients’ care in a timely manner | 99 | 95.7 |
How often the home health team taught patients (or their family caregivers) about their drugs | 100 | 98.6 |
How often the home health team checked patients’ risk of falling | 100 | 99.6 |
How often the home health team checked patients for depression | 100 | 97.4 |
How often the home health team made sure that their patients have received a flu shot for the current flu season. | 86.3 | 78.7 |
How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 89.1 | 82.2 |
With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 100 | 96.4 |
News Archive
ImmunoCellular Therapeutics, Ltd. today announced initiation of a phase I clinical trial of cancer vaccine ICT-121 as a potential treatment for patients with recurrent glioblastoma multiforme.
Pfizer Inc. announced today that the European Commission has granted conditional marketing authorization for BOSULIF (bosutinib) in the European Union for the treatment of adult patients with chronic phase, accelerated phase and blast phase Philadelphia chromosome positive chronic myelogenous leukemia previously treated with one or more tyrosine kinase inhibitor(s) and for whom imatinib, nilotinib and dasatinib are not considered appropriate treatment options.
ClearCount Medical Solutions, an innovator of patient safety solutions for the operating room, announced today that the editors of Popular Science have named the SmartSponge® System one of the top technology innovations of 2009. As a winner off a "Best of What's New" award in the health category, the SmartSponge System stands out as the first and only system to incorporate the efficiency of counting with the safety of detection for the prevention of left-behind sponges during surgery.
A study that included more than 100,000 patients who received implantable cardioverter-defibrillators (ICDs) found that about 20 percent did not meet evidence-based guidelines for receipt of an ICD, and that these patients had a significantly higher risk of in-hospital death than individuals who met criteria for receiving an ICD, according to a study in the January 5 issue of JAMA.
More than 200 CT scans delivered eight times the normal dose of radiation to potential stroke patients in a Los Angeles area hospital since February 2008 because of a scanner reset, The Los Angeles Times reports.
› Verified 7 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often patients got better at walking or moving around | 63.9 | 79.6 |
How often patients got better at getting in and out of bed | 90.7 | 81.1 |
How often patients got better at bathing | 82.3 | 82.3 |
How often patients’ breathing improved | 48.4 | 82.8 |
How often patients’ wounds improved or healed after an operation | - | 92.3 |
How often patients got better at taking their drugs correctly by mouth | 41.2 | 75 |
How often home health patients had to be admitted to the hospital | 13.7 | 15.4 |
How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 7.6 | 13 |
How often physician-recommended actions to address medication issues were completely timely | 100 | 94 |
News Archive
ImmunoCellular Therapeutics, Ltd. today announced initiation of a phase I clinical trial of cancer vaccine ICT-121 as a potential treatment for patients with recurrent glioblastoma multiforme.
Pfizer Inc. announced today that the European Commission has granted conditional marketing authorization for BOSULIF (bosutinib) in the European Union for the treatment of adult patients with chronic phase, accelerated phase and blast phase Philadelphia chromosome positive chronic myelogenous leukemia previously treated with one or more tyrosine kinase inhibitor(s) and for whom imatinib, nilotinib and dasatinib are not considered appropriate treatment options.
ClearCount Medical Solutions, an innovator of patient safety solutions for the operating room, announced today that the editors of Popular Science have named the SmartSponge® System one of the top technology innovations of 2009. As a winner off a "Best of What's New" award in the health category, the SmartSponge System stands out as the first and only system to incorporate the efficiency of counting with the safety of detection for the prevention of left-behind sponges during surgery.
A study that included more than 100,000 patients who received implantable cardioverter-defibrillators (ICDs) found that about 20 percent did not meet evidence-based guidelines for receipt of an ICD, and that these patients had a significantly higher risk of in-hospital death than individuals who met criteria for receiving an ICD, according to a study in the January 5 issue of JAMA.
More than 200 CT scans delivered eight times the normal dose of radiation to potential stroke patients in a Los Angeles area hospital since February 2008 because of a scanner reset, The Los Angeles Times reports.
› Verified 7 days ago
Question Type: | Rating by Patients |
---|---|
Health team gave care in a professional way | Not Available |
Health team communicated well with them | Not Available |
Health team discussed medicines, pain, and home safety | Not Available |
How patients rated overall care from agency | Not Available |
News Archive
ImmunoCellular Therapeutics, Ltd. today announced initiation of a phase I clinical trial of cancer vaccine ICT-121 as a potential treatment for patients with recurrent glioblastoma multiforme.
Pfizer Inc. announced today that the European Commission has granted conditional marketing authorization for BOSULIF (bosutinib) in the European Union for the treatment of adult patients with chronic phase, accelerated phase and blast phase Philadelphia chromosome positive chronic myelogenous leukemia previously treated with one or more tyrosine kinase inhibitor(s) and for whom imatinib, nilotinib and dasatinib are not considered appropriate treatment options.
ClearCount Medical Solutions, an innovator of patient safety solutions for the operating room, announced today that the editors of Popular Science have named the SmartSponge® System one of the top technology innovations of 2009. As a winner off a "Best of What's New" award in the health category, the SmartSponge System stands out as the first and only system to incorporate the efficiency of counting with the safety of detection for the prevention of left-behind sponges during surgery.
A study that included more than 100,000 patients who received implantable cardioverter-defibrillators (ICDs) found that about 20 percent did not meet evidence-based guidelines for receipt of an ICD, and that these patients had a significantly higher risk of in-hospital death than individuals who met criteria for receiving an ICD, according to a study in the January 5 issue of JAMA.
More than 200 CT scans delivered eight times the normal dose of radiation to potential stroke patients in a Los Angeles area hospital since February 2008 because of a scanner reset, The Los Angeles Times reports.
› Verified 7 days ago
The patient survey data of Med-corp Home Health, Inc is compared against the national average with the color code indicators: Better than National Average Worse than National AverageExperience Measure | Provider | National Avg. |
---|---|---|
Percent of patients who reported that their home health team gave care in a professional way | 85 | 88 |
Percent of patients who reported that their home health team communicated well with them | 90 | 85 |
Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 94 | 83 |
Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 95 | 84 |
Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 60 | 78 |
News Archive
ImmunoCellular Therapeutics, Ltd. today announced initiation of a phase I clinical trial of cancer vaccine ICT-121 as a potential treatment for patients with recurrent glioblastoma multiforme.
Pfizer Inc. announced today that the European Commission has granted conditional marketing authorization for BOSULIF (bosutinib) in the European Union for the treatment of adult patients with chronic phase, accelerated phase and blast phase Philadelphia chromosome positive chronic myelogenous leukemia previously treated with one or more tyrosine kinase inhibitor(s) and for whom imatinib, nilotinib and dasatinib are not considered appropriate treatment options.
ClearCount Medical Solutions, an innovator of patient safety solutions for the operating room, announced today that the editors of Popular Science have named the SmartSponge® System one of the top technology innovations of 2009. As a winner off a "Best of What's New" award in the health category, the SmartSponge System stands out as the first and only system to incorporate the efficiency of counting with the safety of detection for the prevention of left-behind sponges during surgery.
A study that included more than 100,000 patients who received implantable cardioverter-defibrillators (ICDs) found that about 20 percent did not meet evidence-based guidelines for receipt of an ICD, and that these patients had a significantly higher risk of in-hospital death than individuals who met criteria for receiving an ICD, according to a study in the January 5 issue of JAMA.
More than 200 CT scans delivered eight times the normal dose of radiation to potential stroke patients in a Los Angeles area hospital since February 2008 because of a scanner reset, The Los Angeles Times reports.
› Verified 7 days ago
Oklahoma Home Health Providers - 1 Location: 351 South 33rd Street, Muskogee, Oklahoma 74401 Ratings: NA Phone: (918) 686-6611 | |
Restore Home Healthcare Of Oklahoma, Llc Location: 124 South 4th Street, Muskogee, Oklahoma 74401 Ratings: Phone: (918) 682-9172 | |
Med-corp Home Health, Inc Location: 3310 Chandler Rd, Muskogee, Oklahoma 74403 Ratings: Phone: (918) 687-8033 | |
Encompass Health Home Health Of Eastern Oklahoma Location: 111 South York Street, Muskogee, Oklahoma 74403 Ratings: Phone: (918) 682-6202 | |
Rainbow Home Health Location: 3308 West Broadway Street, Muskogee, Oklahoma 74401 Ratings: NA Phone: (918) 682-4194 | |
Outreach Home Health Location: 2303 S York Street, Muskogee, Oklahoma 74403 Ratings: Phone: (918) 682-6400 |